Quantum BioPharma Ltd. (NASDAQ:QNTM) — Stock Price
Quantum BioPharma Ltd. (NASDAQ:QNTM) is currently trading at $3.82 USD, down 3.54% today. Over the past 52 weeks, shares have ranged between $2.10 and $18.45. This page tracks Quantum BioPharma Ltd.'s live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Quantum BioPharma Ltd. cash conversion from operations.
Quantum BioPharma Ltd. (QNTM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Quantum BioPharma Ltd.'s daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Quantum BioPharma Ltd. Income Statement — Revenue, Profit & Earnings by Year
Quantum BioPharma Ltd.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $555.33K | $490.57K | — | — | — |
| Gross Profit | $-555.33K | $-490.57K | — | — | — |
| Research & Development | $2.76 Million | $6.08 Million | $3.86 Million | $6.91 Million | $6.33 Million |
| SG&A | $12.01 Million | $9.31 Million | $13.20 Million | $15.98 Million | $23.37 Million |
| Total Operating Expenses | $15.30 Million | $16.14 Million | $23.79 Million | $27.43 Million | $33.74 Million |
| Operating Income | $-15.30 Million | $-16.14 Million | $-23.79 Million | $-27.43 Million | $-33.74 Million |
| EBITDA | $-25.79 Million | $-14.38 Million | $-15.72 Million | $-22.12 Million | $-29.82 Million |
| EBIT | $-26.34 Million | $-14.87 Million | $-18.23 Million | $-26.65 Million | $-33.87 Million |
| Interest Expense | $618.64K | $47.58K | $299.00 | $48.82K | $69.40K |
| Income Before Tax | $-26.96 Million | $-14.92 Million | $-18.23 Million | $-26.70 Million | $-33.94 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-26.18 Million | $-14.20 Million | $-17.90 Million | $-23.61 Million | $-35.29 Million |
Quantum BioPharma Ltd. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Quantum BioPharma Ltd.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $11.14 Million | $17.12 Million | $17.47 Million | $38.41 Million | $62.96 Million |
| Total Current Assets | $6.47 Million | $12.05 Million | $11.09 Million | $17.85 Million | $45.93 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $4.27 Million | $1.20 Million | $756.10K | $23.19K | $158.04K |
| Net Receivables | $230.63K | $3.81 Million | $7.42 Million | $374.38K | $500.96K |
| Inventory | $52.04K | $117.24K | $0.00 | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $6.05 Million | $6.68 Million | $4.57 Million | $7.87 Million | $8.83 Million |
| Total Current Liabilities | $6.05 Million | $6.68 Million | $4.57 Million | $7.83 Million | $8.70 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-29.09K | $-5.17 Million | $-2.42 Million | $-16.46 Million | $-34.70 Million |
| Total Stockholder Equity | $6.91 Million | $11.48 Million | $13.24 Million | $30.54 Million | $54.13 Million |
| Retained Earnings | $-197.93 Million | $-172.11 Million | $-157.91 Million | $-144.16 Million | $-126.15 Million |
Quantum BioPharma Ltd. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Quantum BioPharma Ltd. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-8.38 Million | $-6.88 Million | $-10.83 Million | $-28.33 Million | $-20.75 Million |
| Capital Expenditures | $0.00 | $1.43 | $2.20 | $363.96K | $500.00K |
| Free Cash Flow | $-8.38 Million | $-6.88 Million | $-10.83 Million | $-28.70 Million | $-21.25 Million |
| Investing Cash Flow | $-1.99 Million | $-1.50 Million | $-269.58K | $12.12 Million | $268.96K |
| Financing Cash Flow | $6.21 Million | $11.62 Million | $-3.13 Million | $-2.07 Million | $38.21 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $2.95 Million | $152.21K | $3.84 Million | $1.53 Million | $7.44 Million |
| Depreciation | $555.33K | $490.57K | $2.51 Million | $4.53 Million | $4.05 Million |
| Change in Cash | $-4.09 Million | $3.24 Million | $-14.22 Million | $-18.28 Million | $17.73 Million |
Quantum BioPharma Ltd. Earnings History — EPS Actual vs. Analyst Estimates
Track Quantum BioPharma Ltd.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 13, 2026 | -0.47 | -0.59 | +20.34% |
| May 06, 2026 | -4.17 | -0.68 | -513.24% |
| Nov 06, 2025 | -1.77 | -3.70 | +52.16% |
| Aug 06, 2025 | -3.06 | 0.00 | — |
| May 12, 2025 | -2.33 | — | — |
| Mar 28, 2025 | -2.70 | — | — |
| Nov 12, 2024 | -4.17 | -3.90 | -6.92% |
| Aug 14, 2024 | -5.20 | -3.90 | -33.33% |